Publications by authors named "Benedikt Simbrunner"

Claim this Profile
T
The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis.
Lukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, Mathias Jachs, Benedikt Silvester Hofer

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLD.
Nina Dominik, Larissa Nixdorf, Michael Schwarz, Benedikt Silvester Hofer, Lukas Hartl, Benedikt Simbrunner

Ultraschall Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis.
Enrique Ángel-Gomis, Esther Caparrós, Isabel Gómez-Hurtado, Sebastián Martínez-López, Ani Gasparyan, Benedikt Simbrunner

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model.
Ahmed Ghallab, Maiju Myllys, Daniela González, Adrian Friebel, Zaynab Hobloss, Benedikt Simbrunner

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End-Stage Liver Disease-Authors' Reply.
Mattias Mandorfer, Benedikt Simbrunner, Diana Julie Leeming

Aliment Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades.
Nikolaus Pfisterer, Florian Riedl, Michael Schwarz, Benedikt Simbrunner, Nina Dominik

Gastrointest Endosc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80].
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, Iranzu Ezcurra, Virginia Hernández-Gea

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death.
Mathias Jachs, Tânia Carvalho, Benedikt Simbrunner, Georg Semmler, Lukas Hartl

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related Death.
Caroline Schwarz, Andrea Kornfehl, Reema Abid, Theresa Müllner-Bucsics, Julia Kappel, Benedikt Simbrunner

United European Gastroenterol J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failure.
Georg Kramer, Vlad Taru, Benedikt Simbrunner, Lorenz Balcar, Nina Dominik

Ann Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative Study.
Christian Sebesta, Mathias Jachs, Lukas Hartl, Michael Schwarz, Lorenz Balcar, Benedikt Simbrunner

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis.
Nina Dominik, Benedikt Simbrunner, Bernhard Scheiner, Michael Schwarz, Lukas Hartl

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver Disease.
Dragana Rajcic, Beatriz Pereira da Silva, Taras Baranovskyi, Benedikt Simbrunner, Benedikt S Hofer

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLD.
Lorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure.
Vlad Taru, Georg Kramer, Benedikt S Hofer, Nina Dominik, Lorenz Balcar, Benedikt Simbrunner

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease.
Benedikt Simbrunner, Ida Falk Villesen, Georg Semmler, Lorenz Balcar, Georg Kramer

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile acid signaling in MASLD: From pathogenesis to therapeutic applications.
Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approach.
Alexander Herold, Daniel Sobotka, Lucian Beer, Nina Bastati, Sarah Poetter-Lang, Benedikt Simbrunner

Eur Radiol Exp· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis.
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, Iranzu Ezcurra, Virginia Hernández-Gea

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Course of Portal Hypertension and Applicability of Noninvasive Tests After Recompensation in Alcohol-related Cirrhosis.
Benedikt Silvester Hofer, Georg Semmler, Benedikt Simbrunner, Georg Kramer, Mattias Mandorfer

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models.
Thomas Sorz-Nechay, Ksenia Brusilovskaya, Philipp Königshofer, Benedikt S Hofer, Oleksandr Petrenko, Benedikt Simbrunner

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: 'Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis' [J Hepatol (2024) 80:268-281].
Ahmed Ghallab, Daniela González, Ellen Strängberg, Ute Hofmann, Maiju Myllys, Benedikt Simbrunner

J Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Carvedilol Remains the First-Line Treatment of Portal Hypertension After the CALIBRE Trial.
Thomas Reiberger, Benedikt Simbrunner

Aliment Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis.
Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, Ksenia Brusilovskaya, Oleksandr Petrenko

United European Gastroenterol J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals.
Georg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, Sarah Shalaby, Juan I Sánchez-Avila, Benedikt Simbrunner

JHEP Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis